Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...
MedShift, the premier innovator in medical aesthetic technology has announced that it will bring its product and service...
Australian pharmaceutical firm, Phebra, has announced a collaboration and licensing agreement with the University o...
Mallinckrodt plc a leading global specialty pharmaceutical company has announced that INOmax™ (nitric...
Medical imaging IT and cybersecurity company Sectra has signed a 13-year contract with NSW Health in Australia for ...
A device the size of a small paperclip, created to give people with severe paralysis the ability to communicate again, h...
Dimension Data and Nippon Telegraph and Telephone Corporation (NTT) have entered into a Memorandum of Understanding...
Harvest One Cannabis Inc. through its wholly-owned subsidiary Satipharm Ltd. has entered into an agreement to become a s...
A team of researchers from the Centre for Nanoscale BioPhotonics (CNBP) in Australia has developed a new automated non-i...
Australian oncology-focused biotech company Kazia Therapeutics Ltd has been selected to present data from the Phase I st...
60 Degrees Pharmaceuticals (60P) and its Australian distribution partner Biocelect Pty Ltd, began commercialising the ne...
Vertex Pharmaceuticals Incorporated has announced that the Therapeutic Goods Administration (TGA) of Australia has grant...
SpeeDx has announced signing new partners Al Zahrawi Medical Supplies LLC for distribution of ResistancePlus®&n...
A research team led by Dr Ben Goudey at IBM Research – Australia is using machine learning (ML) to ident...
Atos, a global leader in digital transformation, has signed an AUD124 million (approx. EUR78.2 ...
Medicines Australia recently recognised the extraordinary talent in the Australian Pharmaceutical sector workforce at th...
Kezar Life Sciences, a South San Francisco-based clinical-stage biotechnology company discovering and developing n...
The Australian Government is investing more than $200 million to list four new breakthrough cancer treatments on the Pha...
